Atlas Trials

Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer

Clinical trial NCT00427427 · TERMINATED

Trial details

NCT number
NCT00427427
Sponsor
Jonsson Comprehensive Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2007-01-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.